The United States Patent and Trademark Office (USPTO) has
launched a new platform that could expedite the development of
COVID-19 related technologies. As explained in the USPTO's
press release, the Patents 4 Partnerships web-based marketplace is
designed to “facilitate the voluntary licensing and
commercialization of innovations in a variety of key
technologies” related to “the prevention, treatment,
and diagnosis of COVID-19.”
The Patents 4 Partnerships IP marketplace platform currently
lists 175 granted U.S. patents and pending U.S. patent
applications, covering such diverse technologies as “Methods
of Treating Coronavirus Infection,” “Air-Sampling
Device and Method of Use,” “Rapid and Highly Fieldable
Viral Diagnostic,” and “Dexterous Humanoid Robotic
Wrist.” According to the press release, the initially listed
items were “drawn from a variety of public sources, including
the USPTO, the Federal Laboratory Consortium for Technology
Transfer (FLC Business), the
